keyword
https://read.qxmd.com/read/38157026/the-role-of-beta-adrenoreceptors-in-postoperative-ileus-in-rats
#1
JOURNAL ARTICLE
Bitel Marcin, Sztormowska-Achranowicz Katarzyna, Kocić Ivan
The aim of the research was to evaluate the influence of antagonists of specific beta-adrenergic receptor subtypes on bowel motility following abdominal surgery in rat model of postoperative ileus. Bowel motility was measured by the intestinal transit of Evans blue introduced via orogastric tube after surgical procedures of skin incision, laparotomy and laparotomy with gut manipulation. Male rats were given individual adrenergic receptor subtypes antagonists intraperitoneally, and the influence of administered agents on intestinal transit of Evans blue was then evaluated...
December 29, 2023: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/37725114/the-beta2-adrenergic-agonist-salbutamol-synergizes-with-paclitaxel-on-cell-proliferation-and-tumor-growth-in-triple-negative-breast-cancer-models
#2
JOURNAL ARTICLE
Martina Jabloñski, María Sol Rodríguez, Ezequiel Mariano Rivero, Carlos David Bruque, Silvia Vanzulli, Ariana Bruzzone, Cecilia Pérez Piñero, Isabel Alicia Lüthy
PURPOSE: Globally breast cancer accounts for 24.5% in incidence and 15.5% in cancer deaths in women. The triple-negative subtype lacks any specific therapy and is treated with chemotherapy, resulting in significant side-effects. We aimed to investigate if the dose of chemotherapeutic drugs could be diminished by co-administering it with the β2-agonist salbutamol. METHODS: Cell proliferation was measured by thymidine incorporation; gene expression, by real-time PCR and protein phosphorylation by WB...
September 19, 2023: Cancer Chemotherapy and Pharmacology
https://read.qxmd.com/read/37721175/clinical-and-genetic-characterisation-of-a-large-indian-congenital-myasthenic-syndrome-cohort
#3
JOURNAL ARTICLE
Kiran Polavarapu, Balaraju Sunitha, Ana Töpf, Veeramani Preethish-Kumar, Rachel Thompson, Seena Vengalil, Saraswati Nashi, Mainak Bardhan, Sai Bhargava Sanka, Akshata Huddar, Gopikrishnan Unnikrishnan, Gautham Arunachal, Manu Santhappan Girija, Anna Porter, Yoshiteru Azuma, Paulo José Lorenzoni, Dipti Baskar, Ram Murthy Anjanappa, Madassu Keertipriya, Hansashree Padmanabh, Ganaraja Valakunja Harikrishna, Steve Laurie, Leslie Matalonga, Rita Horvath, Atchayaram Nalini, Hanns Lochmüller
Congenital myasthenic syndromes are a rare group of inherited disorders caused by gene defects associated with the neuromuscular junction and potentially treatable with commonly available medications such as acetylcholinesterase inhibitors and beta2 adrenergic receptor agonists. In this study we identify and genetically characterise the largest cohort of congenital myasthenic syndrome patients from India to date. Clinically suspected patients evaluated in a South Indian hospital between 2014-2019 underwent genetic testing either by standard diagnostic methods of gene panel testing or a two-step method of hotspot screening followed by whole-exome sequencing...
September 18, 2023: Brain
https://read.qxmd.com/read/37629018/%C3%AE-2-adrenergic-receptor-mediated-inhibition-of-t-cell-function-and-its-implications-for-car-t-cell-therapy
#4
REVIEW
Muhammad Asad Farooq, Iqra Ajmal, Xinhui Hui, Yiran Chen, Yaojun Ren, Wenzheng Jiang
The microenvironment of most tumors is complex, comprising numerous aspects of immunosuppression. Several studies have indicated that the adrenergic system is vital for controlling immunological responses. In the context of the tumor microenvironment, nor-adrenaline (NA) is poured in by innervating nerves and tumor tissues itself. The receptors for nor-adrenaline are present on the surfaces of cancer and immune cells and are often involved in the activation of pro-tumoral signaling pathways. Beta2-adrenergic receptors (β2-ARs) are an emerging class of receptors that are capable of modulating the functioning of immune cells...
August 16, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37502964/increased-beta2-adrenergic-signaling-is-a-targetable-stimulus-essential-for-bone-healing-by-promoting-callus-neovascularization
#5
Denise Jahn, Paul Richard Knapstein, Ellen Otto, Paul Köhli, Jan Sevecke, Frank Graef, Christine Graffmann, Melanie Fuchs, Shan Jiang, Mayla Rickert, Cordula Erdmann, Jessika Appelt, Lawik Revend, Quin Küttner, Jason Witte, Adibeh Rahmani, Georg Duda, Weixin Xie, Antonia Donat, Thorsten Schinke, Andranik Ivanov, Mireille Ngokingha Tchouto, Dieter Beule, Karl-Heinz Frosch, Anke Baranowsky, Serafeim Tsitsilonis, Johannes Keller
Traumatic brain injury (TBI) is associated with a hyperadrenergic state and paradoxically causes systemic bone loss while accelerating fracture healing. Here, we identify the beta2-adrenergic receptor (Adrb2) as a central mediator of these skeletal manifestations. While the negative effects of TBI on the unfractured skeleton can be explained by the established impact of Adrb2 signaling on bone formation, Adrb2 promotes neovascularization of the fracture callus under conditions of high sympathetic tone, including TBI and advanced age...
July 16, 2023: bioRxiv
https://read.qxmd.com/read/37265542/novel-therapeutic-targets-to-halt-the-progression-of-parkinson-s-disease-an-in-depth-review-on-molecular-signalling-cascades
#6
REVIEW
S K Meheronnisha, Dithu Thekkekkara, Amrita Babu, Y Mohammed Tausif, S N Manjula
Recent research has focused mostly on understanding and combating the neurodegenerative mechanisms and symptoms of Parkinson's disease (PD). Moreover, developing novel therapeutic targets to halt the progression of PD remains a key focus for researchers. As yet, no agents have been found to have unambiguous evidence of disease-modifying actions in PD. The primary objective of this review is to summarize the promising targets that have recently been uncovered which include histamine 4 receptors, beta2 adrenergic receptor, phosphodiesterase 4, sphingosine-1-phosphate receptor subtype 1, angiotensin receptors, high-mobility group box 1, rabphilin-3A, purinergic 2Y type 12 receptor, colony-stimulating factor-1 receptor, transient receptor potential vanilloid 4, alanine-serine-cysteine transporter 2, G protein-coupled oestrogen receptor, a mitochondrial antiviral signalling protein, glucocerebrosidase, indolamine-2,3-dioxygenase-1, soluble epoxy hydroxylase and dual specificity phosphatase 6...
July 2023: 3 Biotech
https://read.qxmd.com/read/37123375/the-cholinergic-anti-inflammatory-pathway-inhibits-inflammation-without-lymphocyte-relay
#7
JOURNAL ARTICLE
Thomas Simon, Joseph Kirk, Nikola Dolezalova, Mélanie Guyot, Clara Panzolini, Alexandre Bondue, Julien Lavergne, Sandrine Hugues, Nicolas Hypolite, Kourosh Saeb-Parsy, Justin Perkins, Eric Macia, Arun Sridhar, Margriet J Vervoordeldonk, Nicolas Glaichenhaus, Matteo Donegá, Philippe Blancou
The magnitude of innate inflammatory immune responses is dependent on interactions between peripheral neural and immune cells. In particular, a cholinergic anti-inflammatory pathway (CAP) has been identified in the spleen whereby noradrenaline (NA) released by splenic nerves binds to ß2-adrenergic receptors (β2-AR) on CD4+ T cells which, in turn, release acetylcholine (ACh). The binding of ACh to α7 acetylcholine receptors (α7-AChR) expressed by splenic macrophages inhibits the production of inflammatory cytokines, including tumor necrosis factor (TNF)...
2023: Frontiers in Neuroscience
https://read.qxmd.com/read/36300129/biomarkers-in-the-diagnostic-algorithm-of-myalgic-encephalomyelitis-chronic-fatigue-syndrome
#8
JOURNAL ARTICLE
Sabine Gravelsina, Anda Vilmane, Simons Svirskis, Santa Rasa-Dzelzkaleja, Zaiga Nora-Krukle, Katrine Vecvagare, Angelika Krumina, Iana Leineman, Yehuda Shoenfeld, Modra Murovska
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease that is mainly diagnosed based on its clinical symptoms. Biomarkers that could facilitate the diagnosis of ME/CFS are not yet available; therefore, reliable and clinically useful disease indicators are of high importance. The aim of this work was to analyze the association between ME/CFS clinical course severity, presence of HHV-6A/B infection markers, and plasma levels of autoantibodies against adrenergic and muscarinic acetylcholine receptors...
2022: Frontiers in Immunology
https://read.qxmd.com/read/36234730/synthesis-molecular-docking-and-preclinical-evaluation-of-a-new-succinimide-derivative-for-cardioprotective-hepatoprotective-and-lipid-lowering-effects
#9
JOURNAL ARTICLE
Muhammad Imran Qayyum, Sami Ullah, Umer Rashid, Abdul Sadiq, Obaidullah, Mater H Mahnashi, Osama M Alshehri, Mohammed M Jalal, Khalid J Alzahrani, Ibrahim F Halawani
Cardiac and hepatotoxicities are major concerns in the development of new drugs. Better alternatives to other treatments are being sought to protect these vital organs from the toxicities of these pharmaceuticals. In this regard, a preclinical study is designed to investigate the histopathological effects of a new succinimide derivative (Comp-1) on myocardial and liver tissues, and the biochemical effects on selected cardiac biomarkers, hepatic enzymes, and lipid profiles. For this, an initially lethal/toxic dose was determined, followed by a grouping of selected albino rats into five groups (each group had n = 6)...
September 21, 2022: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/36167077/dimerization-of-%C3%AE-2-adrenergic-receptor-is-responsible-for-the-constitutive-activity-subjected-to-inverse-agonism
#10
JOURNAL ARTICLE
Yonghoon Kwon, Do-Hyeon Kim, Min Gyu Jeong, Minh-Triet Hong, Soyeon Park, Yeonho Chang, Kai Zhou, Seung-Yeol Park, Jin Zhang, Sung Ho Ryu
Dimerization of beta 2-adrenergic receptor (β2 -AR) has been observed across various physiologies. However, the function of dimeric β2 -AR is still elusive. Here, we revealed that dimerization of β2 -AR is responsible for the constitutive activity of β2 -AR generating inverse agonism. Using a co-immunoimmobilization assay, we found that transient β2 -AR dimers exist in a resting state, and the dimer was disrupted by the inverse agonists. A Gαs preferentially interacts with dimeric β2 -AR, but not monomeric β2 -AR, in a resting state, resulting in the production of a resting cAMP level...
September 20, 2022: Cell Chemical Biology
https://read.qxmd.com/read/36163241/adrb2-expression-predicts-the-clinical-outcomes-and-is-associated-with-immune-cells-infiltration-in-lung-adenocarcinoma
#11
JOURNAL ARTICLE
Lingyun Ji, Fei Xu, Jingtao Zhang, Ting Song, Weida Chen, Xi Yin, Qingqing Wang, Xiubao Chen, Xin Li, Minghao Guo, Zetao Chen
The gene encoding beta2-adrenergic receptor (β2-AR), adrenoceptor beta 2 (ADRB2), has been reported to closely associated with various cancers. However, its role in lung adenocarcinoma (LUAD) remains controversial. This research shed light on the prognostic value of ADRB2 in LUAD and further explored its association with immune cell infiltration. ADRB2 was significantly decreased in LUAD. ADRB2 expression in LUAD was significantly correlated with gender, smoking status, T classification, and pathologic stage...
September 26, 2022: Scientific Reports
https://read.qxmd.com/read/35872415/covalent-immobilization-of-beta2-adrenergic-receptor-through-trans-methylation-reaction-by-snap-tag-and-its-application-in-anti-asthmatic-compound-screening-from-raphani-semen
#12
JOURNAL ARTICLE
Jing Wang, Qiuyu Gao, Jiatai Yin, Xiaomin Huang, Taotao Wang, Peng Zhang, Qian Li, Xinfeng Zhao
Beta2-adrenergic receptor (β2 -AR) is believed as an attractive target for anti-asthmatic drugs. Its crystal structure and pharmacological activity have been clearly investigated. Yet the number of the approved anti-asthmatic drugs has declined in recent years. This work reports on the preparation of an immobilized β2 -AR column through the specific trans-methylation reaction between SNAP tag and the benzyl-guanine derivative and application in anti-asthmatic compound screening from Raphani Semen. The characterization of the immobilized β2 -AR was performed by scanning electron microscopy (SEM) and receptor-ligand interaction analysis by chromatographic methods...
September 20, 2022: Journal of Pharmaceutical and Biomedical Analysis
https://read.qxmd.com/read/35616052/asthma-education-and-its-impact-on-pediatric-asthma-severity-a-prospective-cohort-study
#13
JOURNAL ARTICLE
Heba Omara, Mervet Gamal, Raffay Mohamed
Objective: Asthma education has been shown to improve asthma control. Our goal was to evaluate the efficacy of asthma education on the frequency of utilization of health-care services, lung function results, degree of asthma severity, and quality of life (QOL) level in children with asthma. Methods: A single-arm prospective interventional trial was conducted in a tertiary facility. Thirty children with asthma and their parents were recruited for the research. Following an assessment of the participants' and caregivers' knowledge about asthma using an asthma knowledge questionnaire, degree of asthma control using asthma control test, inhaler technique using standardized inhaler technique checklists, and QOL using pediatric asthma QOL questionnaires, they participated in a three-month education program in the form of monthly live interactive sessions followed by weekly phone interviews...
May 26, 2022: Journal of Asthma
https://read.qxmd.com/read/35320605/cardiovascular-events-and-all-cause-mortality-in-patients-with-chronic-obstructive-pulmonary-disease-using-olodaterol-and-other-long-acting-beta2-agonists
#14
JOURNAL ARTICLE
Cristina Rebordosa, Dóra Körmendiné Farkas, Jukka Montonen, Kristina Laugesen, Florian Voss, Jaume Aguado, Ulrich Bothner, Kenneth J Rothman, Kristina Zint, Daniel Mines, Vera Ehrenstein
PURPOSE: We examined the effect of olodaterol on the risk of myocardial ischaemia, cardiac arrhythmia, and all-cause mortality compared with use of other long-acting beta2-agonists (LABAs). Channelling bias was also explored. METHODS: This Danish population-based cohort study used data linked from registries of hospital diagnoses, outpatient dispensings, and deaths. It included patients (aged ≥40 years) with a diagnosis of chronic obstructive pulmonary disease (COPD) who initiated olodaterol or another LABA...
March 23, 2022: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/35115229/influence-of-%C3%AE-2-adrenergic-receptor-genotype-on-longitudinal-measures-of-forced-vital-capacity-in-patients-with-duchenne-muscular-dystrophy
#15
JOURNAL ARTICLE
Eli F Kelley, Troy J Cross, Craig M McDonald, Eric P Hoffman, Luca Bello
The progression of decline in forced vital capacity as percent predicated (FVC%p) is a strong indicator of worsening prognosis in patients with Duchenne muscular dystrophy (DMD). Evidence suggests that ß2 adrenergic (ADRB2) receptors may play a role in determining respiratory function, whereby more functional ADRB2 genotype variants (e.g., Gly16) are associated with improved pulmonary function. The purpose of this study was to determine the influence of ADRB2 genotype on longitudinal measures of FVC%p as a function of age in DMD patients...
January 4, 2022: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/35099251/beta-adrenergic-receptors-gene-polymorphisms-are-associated-with-cardiac-contractility-and-blood-pressure-variability
#16
JOURNAL ARTICLE
L Matuskova, B Czippelova, Z Turianikova, D Svec, Z Kolkova, Z Lasabova, M Javorka
Beta-adrenergic receptors (beta-ARs) play a pivotal role in the cardiovascular regulation. In the human heart beta1- and beta2-ARs dominate in atria as well as in ventricle influencing heart rate and myocardial contractility. Some single nucleotide polymorphisms (SNPs) of beta-ARs might influence cardiovascular function. However, the influence of beta-AR genes SNPs on hemodynamic parameters at rest and their reactivity under stress is still not well known. We aimed to explore the associations between four selected beta-ARs gene polymorphisms and selected cardiovascular measures in eighty-seven young healthy subjects...
December 31, 2021: Physiological Research
https://read.qxmd.com/read/34795998/dysfunction-of-the-autonomic-nervous-system-and-its-role-in-the-pathogenesis-of-septic-critical-illness-review
#17
REVIEW
Y Y Kiryachkov, S A Bosenko, B G Muslimov, M V Petrova
Dysfunction of the autonomic nervous system (ANS) of the brain in sepsis can cause severe systemic inflammation and even death. Numerous data confirmed the role of ANS dysfunction in the occurrence, course, and outcome of systemic sepsis. The parasympathetic part of the ANS modifies the inflammation through cholinergic receptors of internal organs, macrophages, and lymphocytes (the cholinergic anti-inflammatory pathway). The sympathetic part of ANS controls the activity of macrophages and lymphocytes by influencing β2-adrenergic receptors, causing the activation of intracellular genes encoding the synthesis of cytokines (anti-inflammatory beta2-adrenergic receptor interleukin-10 pathway, β2AR-IL-10)...
2021: Sovremennye Tekhnologii V Meditsine
https://read.qxmd.com/read/34781149/paroxetine-mitigates-cardiac-remodelling-by-doxorubicin-and-increases-survival
#18
JOURNAL ARTICLE
Marija Kosić, Zorica Nešić, Sofija Glumac, Marko Vasić, Vladislav Pajović, Bojana Savić, Nina Japundžić-Žigon
Doxorubicin (DOX) is an effective anticancer drug. However, its use is hampered by the development of very mortal cardiomyopathy. Here, we investigate whether the co-administration of the antidepressant paroxetine (P), known to exert beneficial cardiovascular effects, would provide effective cardioprotection. Experiments were performed in male Wistar rats randomly assigned to control group (0.5 mL/kg 0.9% NaCl, i.v., n = 7), DOX group (DOX 5 mg /kg i.v., n = 23) and DOX+P group (DOX 5 mg/kg, i...
January 2022: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/34676534/the-beta-2-adrenergic-receptor-a-re-emerging-target-to-combat-obesity-and-induce-leanness
#19
JOURNAL ARTICLE
Morten Hostrup, Johan Onslev
Treatment of obesity with repurposed or novel drugs is an expanding research field. One approach is to target beta2 -adrenergic receptors because they regulate the metabolism and phenotype of adipose and skeletal muscle tissue. Several observations support a role for the beta2 -adrenergic receptor in obesity. Specific human beta2 -adrenergic receptor polymorphisms are associated with body composition and obesity, for which the Gln27Glu polymorphism is associated with obesity, while the Arg16Gly polymorphism is associated with lean mass in men and the development of obesity in specific populations...
October 22, 2021: Journal of Physiology
https://read.qxmd.com/read/34631323/locating-ligand-binding-sites-in-g-protein-coupled-receptors-using-combined-information-from-docking-and-sequence-conservation
#20
JOURNAL ARTICLE
Ashley Ryan Vidad, Stephen Macaspac, Ho Leung Ng
GPCRs (G-protein coupled receptors) are the largest family of drug targets and share a conserved structure. Binding sites are unknown for many important GPCR ligands due to the difficulties of GPCR recombinant expression, biochemistry, and crystallography. We describe our approach, ConDockSite, for predicting ligand binding sites in class A GPCRs using combined information from surface conservation and docking, starting from crystal structures or homology models. We demonstrate the effectiveness of ConDockSite on crystallized class A GPCRs such as the beta2 adrenergic and A2A adenosine receptors...
2021: PeerJ
keyword
keyword
87076
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.